Conducting clinical research studies with
Call to participate

Archive for the ‘ Memory Loss ’ Category

Observational Alzheimer’s Study

Tuesday, July 5th, 2016
Alzheimer’s patients and healthy volunteers are needed to participate in an exploratory, observational clinical study being conducted in New London at Coastal Connecticut Research. New London County Neurologist Dr. Laurence Radin is the study doctor. The intent of the study is to help diagnose and monitor Alzheimer’s Disease more easily and earlier in the fut
Those who may be eligible to participate in the study are living with mild to moderate memory loss and under the age of 90.
There are 2 study visits over the course of 1 year.  No study drug is involved. The Alzheimer’s patient can continue with his or her usual medication and diet as normal.
There is no cost to participate in this clinical research study, no insurance is needed, and reimbursement is available to the study patient for time and travel. Study tests are non-invasive and are provided at no cost.  Study procedures, including an MRI (if needed) and a EEG are performed at no cost.
If you are interested in participating as an Alzheimer’s patient or as a healthy volunteer, please contact a member of the CCRstudies team today at (860)443-4567 or email Referrals are also welcome.
Coastal Connecticut Research is a member of the Alzheimer’s Foundation of America.Flyer with CCR contact information US Spelling

Mobile Memory Clinic

Tuesday, June 21st, 2016

Memory matters and early detection is key in creating a plan of action for an individual living with memory loss.

Coastal Connecticut Research, (CCRstudies), offers free, confidential memory screenings as part of the Alzheimer’s Foundation of America’s National Memory Screening Program.  Our Mobile Memory Clinics have been conducted at a variety of events and locations throughout Southeastern Connecticut.  On Thursday, June 23rd, we will be conducting no cost memory testing at the Chase Manor Health Fair, 85 Norman Road in Norwich.  The event will run from 1:00 pm – 3:00pm. Residents of Chase Manor and the public are invited to visit our booth to gather information regarding our current clinical research.  Diane Palmer, RN, Site Administrator of Coastal Connecticut Research and Qualified Dementia Care Specialist, will be conducting the free memory screenings.

Those who cannot attend the event who wish to learn more about our no cost memory screenings can contact MaryLou Gannotti at (860)443-4567 or email

CCRstudies to Conduct Mobile Memory Clinic

Friday, March 11th, 2016


CCRstudies is a member of the Alzheimer's Foundation of America.

CCRstudies is a member of the Alzheimer’s Foundation of America.

CCRstudies in New London  will be conducting a Mobile Memory Clinic at the East Lyme Senior Center on Wednesday, March 30th, beginning at 9:30 a.m. Diane Palmer, RN and Qualified Dementia Care Specialist, will administer memory testing to those who register in advance with the East Lyme Senior Center. CCRstudies is a member of the Alzheimer’s Foundation of America. The test serves a key role in the early detection of memory loss in individuals.

In addition to free memory testing, CCRstudies will also present information on current Alzheimer’s Research underway in New London testing an investigational add-on medication.

There is no cost to attend the event, but pre-registration is requested for the memory testing which will begin promptly at 9:30am. Memory Screenings can be set up through the East Lyme Senior Center. For further information on the event, contact MaryLou at CCRstudies at (860)443-4567.

Virtual Dementia Tour

Wednesday, January 20th, 2016

In order to understand someone, you sometimes have to walk the proverbial mile in their shoes. But how can you understand empathize with someone living with memory loss if you yourself are not living with the condition?

Second Wind Dreams, a nonprofit organization based in Georgia, created an opportunity for people to experience what it feels like to live with dementia.  The “Virtual Dementia Tour” has been described as a “scientifically proven method that builds sensitivity and awareness in individuals caring for those with dementia by temporarily altering participants’ physical and sensory abilities.”

Recently, CCRstudies staff was invited to participate in a Virtual Dementia Tour held at Senior Resources Agency on Aging in Norwich, Connecticut. Faith Paddon of Gentiva Health Care has been trained to give the tour and facilitated the event along with Marion Donato of Senior Resources Agency on Aging.

Participants were outfitted with a variety of gear to help simulate the dementia experience.  Those who went on the tour described their five minutes of “living with dementia,” as “scary,” “overwhelming,” “horrible,” “frightening,” and “a rollercoaster ride in which you cannot get off.”  CCRstudies MaryLou Gannotti, whose late father had Alzheimer’s, said about the tour  “I actually felt sad after the tour. All I could think of is what my poor dad had to go through in the later stages of his life.”  She further added, “this was a life altering experience and I would highly recommend someone take a tour if they have the chance.”

Since the Virtual Dementia Tour has been launched, nearly two million people in 17 countries have participated.  The tour has also been used at more than 200 colleges and universities to supplement existing curriculum.

Today, over 5 million Americans are living with dementia. 47 million people worldwide are living with the condition.  Alzheimer’s disease is the 6th leading cause of death in the United States, and there is no cure.  Clinical research is underway throughout the world, and locally in New London, regarding the treatment of Alzheimer’s.

CCRstudies is currently involved in a clinical trial testing an investigational add-on medication for mild to moderate memory loss.  Those interested in learning more about the current memory loss study are welcome to contact a member of the study team at (860)443-4567.



Alzheimer’s Study

Wednesday, November 25th, 2015


Alzheimer’s is a progressive disease of the brain. Brian cells die over a period of several years, and symptoms progress from mild to severe.  Alzheimer’s is one of the leading causes of death in the U.S., and affects over 5 million Americans.

It has been over a decade since the FDA has approved any new medications for the treatment of Alzheimer’s.  Clinical research is currently underway in New London at CCRstudies, testing an investigational add-on medication. The team of investigators includes Laurence Radin, MD, Edward McDermott, Jr., MD, and Andrea Stewart, APRN.   This medication is taken in conjunction with the study patients current dosage of Aricept (Donepezil.)  The investigational medication is designed to improve thinking, memory, reasoning and cognition.  It is the Phase 3 of the clinical trial process.

Those interested in learning more about the Alzheimer’s study underway in New London can contact a member of the CCRstudies team at (860)443-4567, or click on this link for further details

In addition to the study patient, caregivers play an important role in this trial.  There is no cost to participate and compensation is available for time and travel to the study patient and caregiver.

Alzheimer’s Awareness

Friday, October 30th, 2015
CCRstudies is a member of the Alzheimer's Foundation of America.

CCRstudies is a member of the Alzheimer’s Foundation of America.

November is National Alzheimer’s Awareness Month. Volunteers are needed for an Alzheimer’s study being conducted in New London by Dr. Laurence Radin, Dr. Edward McDermott, and Andrea Stewart, APRN.

Alzheimer’s disease is the most common form of dementia in adults 65 and over.  Dementia is a general term which describes a group of symptoms related to the loss of a variety of intellectual functions.  This can include loss in memory, judgment, language and complex motor skills which may interfere with daily living.

The Alzheimer’s Foundation of America notes that “Alzheimer’s disease is not a normal part of aging: however, age is the greatest known risk factor.  Other factors are genetic makeup and chronic untreated health problems such as high blood pressure.”

There is no cure currently available for Alzheimer’s disease, but there are FDA-approved medications available that can help to slow the progression of disease symptoms.

Research is currently underway in New London testing an investigational add-on medication for the treatment of Alzheimer’s. Volunteers with mild to moderate memory loss currently taking Aricept are needed as potential study volunteers. There has been no new medication introduced for the treatment of Alzheimer’s in over a decade.  If you or someone you know, ages 50 or above, is living with mild to moderate memory loss, you may qualify for this research study.  Call a member of the CCRstudies Team at 860-443-4567 today to learn more about how you can be involved in research.  Study participants and caregivers are eligible to receive compensation for their time and travel in addition to no cost study-related care.

Mobile Memory Clinic

Thursday, October 1st, 2015


Residents of Hamilton Park

Residents of Hamilton Park

CCRstudies had the pleasure of taking our show on the road to kick off the month of October.  We conducted a presentation on Alzheimer’s research at the Hamilton Park Apartments in Norwich.  Following the presentation, free memory screenings were held for interested residents as part of the Alzheimer’s Foundation of America’s early detection/screening initiative.

Residents in attendance were gracious and attentive and not only appreciated the information presented, but also had some fun with our free giveaways!  The Alzheimer’s presentation was interactive, and residents asked questions throughout such as “if I lose my keys all the time, does this mean I am losing my mind?” and, “what’s the difference between being senile, having dementia, and having Alzheimer’s?”  People shared their stories of caring for loved ones with Alzheimer’s, and noted how eager they were to participate in the early detection memory screening. Virtually all in attendance had an anecdote to share about someone in their life living with memory disease.  A big “thank you” goes out Tara Dowling of Hamilton Park who invited us to facilitate the event.  We look forward to further connecting with the Norwich community!

Health Wise, The Times

Wednesday, September 23rd, 2015

CCRstudies is proud to have a column in the local Times newspapers called “Health Wise.”
Here is the column which ran recently, highlighting Alzheimer’s and CCRstudies free memory clinics:

September is World Alzheimer’s Month. It is quite likely you or someone you know has been personally touched by memory loss.

Alzheimer’s is a progressive disorder which, in simple terms, kills brain cells and affects memory. The disease is classified in three stages: mild, moderate, and severe. Alzheimer’s is the sixth ranking cause of death nationally.

Currently an estimated 5.1 million Americans have Alzheimer’s and it continues to grow with the aging population. Alzheimer’s is primarily a disease of the aging, typically striking those who are 65 and older. However, dementia, a more general diagnosis, which includes those with Alzheimer’s, is not attached to a certain age group. There are a reported half a million people younger than 65 who are affected by some form of dementia. Hollywood shed a light on this condition last year with the movie “Still Alice,” where Oscar winner Julianne Moore portrayed a middle aged woman living with early onset Alzheimer’s. While this movie was based on a fictional book, the scenario of memory loss at middle age is not uncommon. Younger onset Alzheimer’s comprises up to 5 percent of the over 5 million Americans living with this disease.

Memory disease has widespread affects for the individual living with memory loss, and for his or her caregivers and loved ones. Alzheimer’s has been referred to as “the long goodbye.” This degenerative condition robs people of their thinking, reasoning, and cognitive abilities. It also robs friends and family of those living with the disease of the person they once knew and loved. In many instances, adult children find themselves in the role of “parent” with their own mom or dad. Spouses, as well, take on a new role, and find themselves transitioning from partner to caregiver.

Research for Alzheimer’s disease is being conducted globally, and locally in New London. Most current treatments for Alzheimer’s address the symptoms of the disease and not the underlying cause. It has been over a decade since new medications for Alzheimer’s were introduced to the general public through the FDA. Clinical trials of investigational drugs are currently being tested on volunteers living with memory loss. Caregivers, as well as study volunteers, play an important role in the clinical trial process.

To date, no drug has been found to cure or reverse the symptoms of Alzheimer’s. There is no “magic pill” designed to take away the confusion, agitation, distress and forgetfulness caused by memory disease. Current treatment can help to manage symptoms, but we are not yet at a place where this degenerative disease is being kept at bay. Investigational medications are targeting nerve receptors in the brain important for memory, thinking and reasoning.

Realizing the importance of early detection in memory loss, CCRstudies in New London, in collaboration with the Alzheimer’s Foundation of America, has begun hosting no cost memory clinics in the region. Staff trained as Qualified Dementia Care Specialists are available to conduct free memory testing as a service to the community. To learn more about no cost memory testing for you or your community group or organization, call 860-443-4567, or e-mail Memory testing is private, confidential, and results can be forwarded to your primary care doctor.


Alzheimer’s Talk on the Air

Monday, August 31st, 2015

Recently, CCRstudies had the good fortune of going on the Lee Elci Radio Show on 94.9 News Now.  Lee, an affable host, allowed CCR’s MaryLou Gannotti, Public Relations and Communications Director, to have an open discussion on Alzheimer’s Disease, including promoting CCRstudies no cost memory testing through the Alzheimer’s Foundation of America. MaryLou also talked about the STARBEAM study, a clinical research trial testing an investigation add-on medication for those living with mild to moderate Alzheimer’s Disease.

To hear more, click on the play button below:

To learn more about CCRstudies Free Memory Testing, or the STARBEAM study, call 860-443-4567 or email

Free Memory Clinics

Monday, August 10th, 2015


CCRstudies is a member of the Alzheimer's Foundation of America.

CCRstudies is a member of the Alzheimer’s Foundation of America.

Are you or is someone you know concerned about memory loss?  Has misplacing the keys, forgetting names, and being confused become a part of everyday life?  CCRstudies has recently begun offering no cost memory testing as a service to the community.

CCRstudies in New London has been a part of important clinical research involving memory disease.  As a service to the community, Diane Palmer, RN, CCRC and Site Adminstrator at CCRstudies along with Jessie Jellison, LPN and CRC, have become Qualified Dementia Care Specialists through the Alzheimer’s Foundation of America.  Their certification and advanced training enables them to conduct memory testing, an invaluable part of the process in detecting and ultimately diagnosing memory disease.

CCRstudies is currently conducting a clinical trial testing an investigational “add-on” medication to be used with the Alzheimer’s patients current course of treatment. The research team consists of Dr. Laurence Radin, Dr. Edward McDermott, and Andrea Stewart, APRN.  To learn more, call 860-443-4567.